Responding to COVID-19

12 May 2020

Wideblue is experienced and accredited for the development of medical devices. We thought it would be a good idea to combine GSS sensors into a medical device to make a personal capnometer. We needed a company to carry out the clinical trials and analyse the patient data so we invited Cambridge Respiratory Innovations (CRI) to join the consortium. We applied and won funding. Wideblue led the consortium and we solved all the technical problems and developed the first version of the personal capnometer.

Technology Scotland: Responding to COVID-19: Wideblue

Wideblue
Skip to content